Barriers and supports for adapted physical activity in children and teens with IBD
Official title: Analysis of Barriers and Facilitators to Adapted Physical Activity for Pediatric Patients With Chronic Inflammatory Bowel Diseases
Run by Fondation Lenval · NCT07383844 · Data updated 2026-11-12
This project will ask children and teens (10–17) with Crohn's disease or ulcerative colitis about what helps or stops them from staying active to find ways to support regular physical activity.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 10 Years to 17 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Fondation Lenval Academic / other |
| Locations | 1 site (Nice) |
| Status | Recruiting |
| Started | January 21, 2026 |
| Main results expected | January 31, 2027 |
| Study ends | January 31, 2027 |
| Registry record updated | February 3, 2026 |
| Trial ID | NCT07383844 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are 10–17-year-olds with a confirmed diagnosis of Crohn's disease or ulcerative colitis for at least six months who are followed at Hôpital Lenval and can complete questionnaires and a one-on-one interview.
✕Probably not a fit
Those newly diagnosed (less than six months), with other chronic conditions or major cognitive or language barriers, or those seeking direct medical treatment changes are unlikely to receive direct benefit from participating.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will enroll about 60 adolescents aged 10–17 with Crohn's disease or ulcerative colitis followed at Hôpital Lenval. Participants will complete two self-administered questionnaires (CAPAS-Q for activity/sedentary behavior and IMPACT-III for health-related quality of life) and take part in a single semi-structured interview about experiences, obstacles, and supports for physical activity. Relevant clinical data including disease characteristics, treatment, and routine clinical parameters will be extracted from medical records to contextualize responses. Participation requires a single 45–60 minute visit during a routine hospital appointment with no additional intervention or follow-up.
Why it matters
Potential benefit: If successful, the findings could help design programs or clinical supports that make it easier for children and teens with IBD to be more active and improve quality of life.
How similar studies have gone: Prior questionnaire and interview studies in pediatric chronic illnesses, including some work in IBD, have successfully identified barriers to activity and helped guide intervention design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 10 to 17 years at inclusion. * Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis) confirmed and diagnosed for at least 6 months. * Followed in the pediatric gastroenterology department at Hôpital Lenval (CHU de Nice). * Sufficient cognitive and language abilities to understand questionnaires and participate in an individual interview. * Affiliated to, or beneficiary of, a social security scheme. * no parental objection to participation (non-opposition). Exclusion Criteria: * Younger than 10 years or older than 17 years. * No IBD diagnosis, or IBD diagnosed less than 6 months ago. * Associated chronic condition (neurological, metabolic, psychiatric, or other) likely to interfere with questionnaire completion or interview participation. * Major language or cognitive impairment preventing adequate understanding or interview participation. * Not affiliated to, or not beneficiary of, a social security scheme.
Where it's running
-
Fondation Lenval Hôpitaux pédiatrique Nice CHU Lenval
Nice, France Recruiting
Study contacts
- Study coordinator: Aline Joulie
- Email: joulie.a@chu-nice.fr
- Phone: 0492030520
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Innovative Multidisciplinary and Virtual Care for IBD in Pregnancy
This study tests a dedicated IBD pregnancy care model, including a new virtual approach, to see if it improves access and quality of care for pregnant people with Crohn's disease or ulcerative colitis.
-
A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis
A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.
-
Advanced therapies for moderately to severely active Crohn's disease or ulcerative colitis in adults
This study tests combinations of risankizumab with either trosunilimab or ABBV-701 in adults with moderately to severely active Crohn's disease or ulcerative colitis.
-
Longitudinal Immunophenotyping of People with Inflammatory Bowel Disease
This study will follow adults with Crohn's disease or ulcerative colitis (and some healthy relatives) over three years to see how their immune cells change over time and how genetics and diet relate to their disease.
-
High Protein, High Fiber Diet for Ulcerative Colitis
This study tests a high-protein, high-fiber diet to see if it helps people with ulcerative colitis by meeting protein needs and lowering harmful hydrogen sulfide production in the gut.
-
Ath-063: Testing a new treatment for moderately to severely active ulcerative colitis in patients who have tried other biologics
This study tests ATH-063 to see if it helps people with moderate to severe ulcerative colitis who did not respond to or relapsed after prior biologic therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.